Spiriva (tiotropium bromide) is a long-acting bronchodilator prescribed for certain respiratory conditions. It isn’t meant for sudden breathing problems. You should not combine Spiriva with other ...

Spiriva (tiotropium) is a prescription drug used to treat specific breathing conditions. Spiriva’s cost may depend on factors such as your dosage, whether you have health insurance, and the pharmacy ...

Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) is now available for the long-term maintenance treatment of asthma in patients ages ≥12 years. Boehringer Ingelheim announced ...

Spiriva (tiotropium bromide) is an anticholinergic medication that relaxes airway muscles to ease breathing in chronic obstructive pulmonary disease (COPD) and asthma. It’s meant for long-term daily ...

Spiriva is a long-term maintenance medication taken once per day to keep the airways in the lungs open. But it should never be used as a rescue inhaler for sudden breathing emergencies. You take ...

LONDON, Sept 24 (Reuters) - Results of a clinical study to be presented next month show the blockbuster inhaled lung drug Spiriva, marketed by Pfizer and Boehringer Ingelheim, actually cuts heart risk ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Spiriva Respimat for the long-term, once-daily treatment of asthma in patients aged 12 years ...

Lupin has received the Food and Drug Administration’s permission for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, which is a generic of Boehringer Ingelheim’s Spiriva HandiHaler. The ...

Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...

Spiriva, a drug that is already widely used to treat chronic obstructive pulmonary disease, can provide significant relief of symptoms for adult asthmatics who have difficulty obtaining relief with ...

WASHINGTON (Reuters) - The lung drug Spiriva, marketed by Pfizer Inc and Boehringer Ingelheim Pharmaceutical Inc, may increase the risk of stroke, the U.S. Food and Drug Administration said on Tuesday ...

Researchers say they've found a possible new treatment for adults with hard-to-control asthma. Their discovery, however, came at a price. Scientists of a U.S. government-funded asthma study had to ...